Characterization and Antimicrobial Assessment of Cadmium Sulfide Nanoparticles.

Ezinne Uchechi Ekwujuru, Moses Gbenga Peleyeju, Cornelius Ssemakalu, Mzimkhulu Monapathi, Michael Klink

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ezinne Uchechi EkwujuruDepartment of Natural Sciences, Faculty of Applied and Computer Sciences, Vaal University of Technology, Vanderbijlpark Campus, Vanderbijlpark 1911, South Africa.ORCID 0000-0003-2939-7526

Moses Gbenga PeleyejuDepartment of Natural Sciences, Faculty of Applied and Computer Sciences, Vaal University of Technology, Vanderbijlpark Campus, Vanderbijlpark 1911, South Africa.

Cornelius SsemakaluDepartment of Natural Sciences, Faculty of Applied and Computer Sciences, Vaal University of Technology, Vanderbijlpark Campus, Vanderbijlpark 1911, South Africa.ORCID 0000-0003-3895-2018

Mzimkhulu MonapathiDepartment of Natural Sciences, Faculty of Applied and Computer Sciences, Vaal University of Technology, Vanderbijlpark Campus, Vanderbijlpark 1911, South Africa.

Michael KlinkDepartment of Natural Sciences, Faculty of Applied and Computer Sciences, Vaal University of Technology, Vanderbijlpark Campus, Vanderbijlpark 1911, South Africa.ORCID 0000-0002-9131-6312

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to conventional antibiotics remains a global health challenge. The search for more effective antimicrobial agents has led to the consideration of nanoparticles due to their potential biocidal activities. This study synthesized, characterized, and evaluated the antimicrobial behavior of cadmium sulfide nanoparticles (CdS NPs) during incubations at 37 °C and at room temperature (rt; 23 to 27 °C). XRD results showed that the synthesized nanoparticles had a cubic zinc blende structure, while microscopic investigations confirmed the particle size to be 7.236 nm on average. UV-Vis spectroscopy showed that the nanoparticles are active in the visible light region. Raman spectroscopy results showed peaks at 302.3 cm

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsCadmium CompoundsMetal NanoparticlesNanoparticlesSulfidesEscherichia coliMicrobial Sensitivity TestsParticle SizeStaphylococcus aureusX-Ray DiffractionAnti-Bacterial AgentsAnti-Infective AgentsCadmium Compoundscadmium sulfideSulfidesantimicrobial resistancebactericidal agentscadmium sulfidenanoparticles

Identifiers

PMID41516302

DOI10.3390/ijms27010432

PMCPMC12787143

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.